TPWM
Twelve Points Wealth Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
6,769
+375
| +6% | +$69.6K | 0.34% | 73 |
|
|
2025
Q1 | $1.34M | Sell |
6,394
-383
| -6% | -$80.2K | 0.36% | 67 |
|
|
2024
Q4 | $1.2M | Buy |
6,777
+642
| +10% | +$114K | 0.35% | 69 |
|
|
2024
Q3 | $1.21M | Buy |
6,135
+508
| +9% | +$100K | 0.38% | 63 |
|
|
2024
Q2 | $965K | Buy |
5,627
+372
| +7% | +$63.8K | 0.34% | 75 |
|
|
2024
Q1 | $957K | Buy |
5,255
+336
| +7% | +$61.2K | 0.35% | 69 |
|
|
2023
Q4 | $762K | Buy |
4,919
+308
| +7% | +$47.7K | 0.36% | 78 |
|
|
2023
Q3 | $687K | Buy |
4,611
+244
| +6% | +$36.4K | 0.34% | 81 |
|
|
2023
Q2 | $588K | Buy |
4,367
+776
| +22% | +$105K | 0.31% | 90 |
|
|
2023
Q1 | $572K | Buy |
3,591
+307
| +9% | +$48.9K | 0.33% | 90 |
|
|
2022
Q4 | $531K | Sell |
3,284
-15
| -0.5% | -$2.42K | 0.36% | 86 |
|
|
2022
Q3 | $443K | Buy |
3,299
+436
| +15% | +$58.5K | 0.34% | 96 |
|
|
2022
Q2 | $439K | Buy |
2,863
+574
| +25% | +$88K | 0.34% | 107 |
|
|
2022
Q1 | $371K | Buy |
2,289
+658
| +40% | +$107K | 0.28% | 115 |
|
|
2021
Q4 | $221K | Buy |
+1,631
| New | +$221K | 0.18% | 154 |
|